Mirtazapine, serum or plasma-994

Test info

  
Mirtazapine, serum or plasma
  
994
  
LAB994
  
MSO
  
Remeron
  

Therapeutic drug management

Specimen

  
Serum
  
  
2.0 mL
  
0.5 mL
  

Draw just before the next dose

  
  1. Allow sample to clot
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
  
Heparin plasma
  

Dk green heparin (Li or Na), no gel

 

  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  
  1. Spin within two (2) hours of sample collection
  2. Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as the appropriate plasma type
  

Ambient - < 3 days

Refrigerated (OK)

Frozen (OK)

  
  • Gel-barrier tubes

Performance

  
LabCorp Burlington (808414): R-NX
  
Tu, Th, Sat
  
10 - 14 days
  

High-pressure liquid chromatography with fluorescence detection (HPLC/FD)

Clinical and Interpretive info

  

Expected steady-state trough Mirtazapine concentrations in patients receiving recommended daily dosages: 4.0 - 40.0 ng/mL

  

Trough levels are most reproducible

Billing

  
80335
  
Result 17283-3

Tracking

  
08/19/2019
  
03/11/2022
  
12/27/2023